Name: Mathematical Oncology (en Inglés)
SKU: 67481524
Price: 322.92 USD
Availability: InStock
Author: Luigi Preziosi;Mark A. J. Chaplain
ISBN: 9781071649794

portada Mathematical Oncology (en Inglés)

Formato

Libro Físico

Editorial

Springer-Verlag New York Inc.

Autor

Luigi Preziosi;Mark A. J. Chaplain

Colección

Interdisciplinary Applied Mathematics

Año

2027

Idioma

Inglés

N° páginas

857

Encuadernación

Tapa Blanda

Dimensiones

23.5x15.5 cm

ISBN13

9781071649794

Mathematical Oncology (en Inglés)

Luigi Preziosi;Mark A. J. Chaplain (Autor) · Springer-Verlag New York Inc. · Tapa Blanda

Libro Nuevo Importado

Envío: 79 a 88 días háb.

$ 587.13$ 322.92

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 50 unidades

$ 322.92

Llega entre el 21 Ene y el 05 Feb a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Mathematical Oncology (en Inglés)"

Cancer is a complex and devastating disease, responsible for millions of deaths worldwide each year. While traditional oncology focuses on diagnosis and treatment through medical, surgical, radiation and clinical techniques, mathematical oncology has emerged as a powerful discipline that applies mathematical modelling to understand cancer growth, spread, and response to treatment. This volume provides a comprehensive exploration of mathematical approaches in oncology, offering a deep dive into differential equation models and biomechanical models. From reaction-diffusion equations that capture tumour growth and spread, to mechanical models that examine cellular interactions within tissues and vessels, this book presents both analytical techniques and computational modelling approaches that enhance our understanding of cancer dynamics. This book serves as both a reference for researchers and a foundation for integrating mathematical oncology into university curricula. By bridging the gap between mathematics, biology, and clinical research, it highlights the crucial role of mathematical modelling in advancing cancer treatment strategies and improving patient outcomes.